SAIC Announces Fourth Quarter and Full Fiscal Year 2024 Results
- None.
- None.
Insights
The reported figures indicate a mixed financial performance for SAIC. The company has experienced a 7.7% organic growth in Q4 FY24 and a consistent 7.4% for the full FY24, which suggests a stable expansion in their operations. However, the decline in net income by 47% in Q4 compared to the previous year raises concerns. It is important to note the company's operating income has decreased significantly by 33% in Q4 and adjusted EBITDA also saw a decline of 26%. While the full FY24 net income shows an increase of 59%, this might be attributed to specific one-time factors that need to be examined further.
From a shareholder's perspective, the diluted earnings per share (EPS) have decreased by 45% in Q4, which could impact investor sentiment negatively. Nevertheless, the adjusted diluted EPS for the full year shows a slight improvement, indicating some underlying strengths in the business. The updated FY25 guidance with higher revenue and free cash flow projections could be a positive signal for the future, but it is essential to scrutinize the assumptions behind these forecasts.
Investors should also consider the impact of higher incentive-based compensation on the company's expenses, as it has contributed to the changes in net income and EBITDA margins. The reported cash flows from operating activities and transaction-adjusted free cash flow indicate a robust liquidity position, which is important for sustaining investments and handling potential market downturns.
SAIC's performance in the defense, space, civilian and intelligence markets reflects a broader industry trend where technology integrators are playing a pivotal role in digital transformation. The company's organic growth is a positive indicator of its competitive positioning and ability to secure contracts in its core markets. However, the revenue decline of 12% in Q4 FY24 compared to the previous year suggests that there might be challenges in maintaining the growth momentum.
The technology integration sector is highly competitive and SAIC's investments in the next phase of their corporate strategy could be a strategic move to differentiate themselves from competitors. The emphasis on becoming the 'premier mission integrator' might resonate with government and defense contractors seeking specialized services. This strategic pivot could potentially open up new revenue streams and strengthen customer relationships.
It's important for market observers to track how SAIC's strategic investments will translate into financial performance. The company's ability to leverage its expertise to drive value for stakeholders will be critical in sustaining its market position and justifying the higher revenue and free cash flow guidance for FY25.
The reported financial results of SAIC have to be contextualized within the broader economic landscape. The organic growth reported by the company is above average for the industry, indicating that SAIC is outperforming some of its peers. This is a positive sign for the company's resilience in the face of potential macroeconomic headwinds such as inflationary pressures or budgetary constraints on government spending.
The decrease in operating income and EBITDA margins could be a reflection of rising costs, possibly linked to labor or material expenses, which are common economic challenges in the current environment. The higher incentive-based compensation could also be a strategic decision to retain talent amidst a competitive labor market.
Looking ahead, the updated FY25 guidance suggests that SAIC is expecting economic conditions that will allow for revenue growth and improved cash flow. However, investors should remain cautious and consider the possibility of economic downturns that could affect government spending on technology and defense, which are key markets for SAIC.
-
Q4 FY24 revenues of
$1.74 billion 7.7% organic growth(1); FY24 revenues of$7.44 billion 7.4% organic growth(1); organic growth reflects impacts of divestitures and additional five working days in the prior year
-
Q4 FY24 net income of
$39 million $127 million 7.3% of revenue; FY24 net income of$477 million $668 million 9.0% of revenue; impacted by higher incentive-based compensation
-
Q4 FY24 diluted earnings per share of
$0.74 $1.43 $8.88 $7.88
-
Q4 FY24 cash flows provided by operating activities of
$63 million $119 million $396 million $486 million
- Updated FY25 guidance reflects higher revenue and free cash flow(1)
“We delivered strong financial results in the quarter with revenue, earnings per share and free cash flow ahead of expectations,” said Toni Townes-Whitley, SAIC Chief Executive Officer. “As we embark on the next phase of our corporate strategy to become the premier mission integrator in our market, I am confident that the investments we are making in Fiscal Year 2025 will accelerate our ability to drive value for all our stakeholders. I want to thank all of our employees for a strong Fiscal Year 2024, their enthusiasm towards embracing our vision, and their focus on execution of our strategy.”
Fourth Quarter and Full Fiscal Year 2024: Summary Operating Results
|
|
Three Months Ended |
|
Year Ended |
||||||||||||||||||
|
|
February 2,
|
|
Percent
|
|
February 3,
|
|
February 2,
|
|
Percent
|
|
February 3,
|
||||||||||
|
(in millions, except per share amounts) |
|||||||||||||||||||||
Revenues |
|
$ |
1,737 |
|
|
(12 |
)% |
|
$ |
1,968 |
|
|
$ |
7,444 |
|
|
(3 |
)% |
|
$ |
7,704 |
|
Operating income |
|
|
79 |
|
|
(33 |
)% |
|
|
118 |
|
|
|
741 |
|
|
48 |
% |
|
|
501 |
|
Operating income as a percentage of revenues |
|
|
4.5 |
% |
|
-150bps |
|
|
6.0 |
% |
|
|
10.0 |
% |
|
350bps |
|
|
6.5 |
% |
||
Adjusted operating income(1) |
|
|
89 |
|
|
(32 |
)% |
|
|
131 |
|
|
|
519 |
|
|
(1 |
)% |
|
|
526 |
|
Adjusted operating income as a percentage of revenues |
|
|
5.1 |
% |
|
-160bps |
|
|
6.7 |
% |
|
|
7.0 |
% |
|
20bps |
|
|
6.8 |
% |
||
Net income attributable to common stockholders |
|
|
39 |
|
|
(47 |
)% |
|
|
74 |
|
|
|
477 |
|
|
59 |
% |
|
|
300 |
|
EBITDA(1) |
|
|
118 |
|
|
(26 |
)% |
|
|
160 |
|
|
|
891 |
|
|
35 |
% |
|
|
658 |
|
EBITDA as a percentage of revenues |
|
|
6.8 |
% |
|
-130bps |
|
|
8.1 |
% |
|
|
12.0 |
% |
|
350bps |
|
|
8.5 |
% |
||
Adjusted EBITDA(1) |
|
|
127 |
|
|
(26 |
)% |
|
|
171 |
|
|
|
668 |
|
|
(2 |
)% |
|
|
680 |
|
Adjusted EBITDA as a percentage of revenues |
|
|
7.3 |
% |
|
-140bps |
|
|
8.7 |
% |
|
|
9.0 |
% |
|
20bps |
|
|
8.8 |
% |
||
Diluted earnings per share |
|
$ |
0.74 |
|
|
(45 |
)% |
|
$ |
1.34 |
|
|
$ |
8.88 |
|
|
65 |
% |
|
$ |
5.38 |
|
Adjusted diluted earnings per share(1) |
|
$ |
1.43 |
|
|
(30 |
)% |
|
$ |
2.04 |
|
|
$ |
7.88 |
|
|
4 |
% |
|
$ |
7.55 |
|
Net cash provided by operating activities |
|
$ |
63 |
|
|
(57 |
)% |
|
$ |
145 |
|
|
$ |
396 |
|
|
(26 |
)% |
|
$ |
532 |
|
Free cash flow(1) |
|
$ |
97 |
|
|
(34 |
)% |
|
$ |
148 |
|
|
$ |
414 |
|
|
(9 |
)% |
|
$ |
457 |
|
Transaction-adjusted free cash flow(1) |
|
$ |
119 |
|
|
(20 |
)% |
|
$ |
148 |
|
|
$ |
486 |
|
|
6 |
% |
|
$ |
457 |
|
(1)Non-GAAP measure, see Schedule 5 for information about this measure |
||||||||||||||||||||||
The Company utilizes a 52/53 week fiscal year ending on the Friday closest to January 31, with fiscal quarters typically consisting of 13 weeks. Fiscal year 2024 consisted of 52 weeks, while fiscal year 2023 consisted of 53 weeks with the extra week occurring in the fourth quarter.
Fourth Quarter Summary Results
Revenues for the quarter decreased
Operating income as a percentage of revenues decreased to
Adjusted EBITDA(1) as a percentage of revenues for the quarter was
Diluted earnings per share for the quarter was
Fiscal Year 2024 Summary Results
Revenues for the fiscal year decreased
Operating income as a percentage of revenues for the fiscal year was
Adjusted EBITDA(1) as a percentage of revenues for the fiscal year increased to
Diluted earnings per share for the year was
Cash Generation and Capital Deployment
Total cash flows provided by operating activities for the fourth quarter were
Total cash flows provided by operating activities for the year were
During the quarter, SAIC deployed
(1)Non-GAAP measure, see Schedule 5 for information about this measure
Quarterly Dividend Declared
As previously announced, subsequent to fiscal year-end, the Company’s Board of Directors ("Board of Directors") declared a cash dividend of
Backlog and Contract Awards
Net bookings for the quarter were approximately
SAIC’s estimated backlog at the end of fiscal year 2024 was approximately
SAIC was awarded the following contracts during the quarter:
Notable New Awards:
Notable Recompete Awards:
Notable Awards Subsequent to Period End (not included in current quarter bookings):
Other Notable News
SAIC Announces to Realign Organization to Optimize Strategic Pivots and Increase Organic Growth: During the quarter, SAIC announced a business reorganization that replaces its current two operating sectors with five customer facing business groups supported by the enterprise organizations, including the Innovation Factory. The reorganization is effective February 3, 2024 and is designed to enhance management's involvement with customers and advance SAIC’s innovation and go-to-market strategy.
SAIC’s ReadyOne™ software named Big Idea at the 2024 BIG Innovation Awards: The Business Intelligence Group named SAIC’s ReadyOne™ software a winning product at the of the 2024 BIG Innovation Awards. This annual business awards program recognizes organizations, products, and people that are bringing new ideas to life in innovative ways. ReadyOne™ is SAIC’s platform to rapidly install and configure readily usable digital engineering ecosystems for engineering teams and stakeholders.
Fiscal Year 2025 Guidance
The Company's outlook for fiscal year 2025 is being provided. The table below summarizes fiscal year 2025 guidance and represents our views as of March 18, 2024.
|
PRIOR |
CURRENT |
|
Fiscal Year |
Fiscal Year |
|
2025 Guidance |
2025 Guidance |
Revenue |
|
|
Adjusted EBITDA(1) |
- |
|
Adjusted EBITDA Margin %(1) |
|
|
Adjusted Diluted EPS(1) |
|
|
Free Cash Flow(1) |
|
|
(1)Non-GAAP measure, see Schedule 5 for information about this measure |
||
Webcast Information
SAIC management will discuss operations and financial results in an earnings conference call beginning at 10 a.m. Eastern time on March 18, 2024. The conference call will be webcast simultaneously to the public through a link on the Investor Relations section of the SAIC website (http://investors.saic.com). We will be providing webcast access only – “dial-in” access is no longer available. Additionally, a supplemental presentation will be available to the public through links to the Investor Relations section of the SAIC website. After the call concludes, an on-demand audio replay of the webcast can be accessed on the Investor Relations website.
About SAIC
SAIC® is a premier Fortune 500® technology integrator focused on advancing the power of technology and innovation to serve and protect our world. Our robust portfolio of offerings across the defense, space, civilian and intelligence markets includes secure high-end solutions in mission IT, enterprise IT, engineering services and professional services. We integrate emerging technology, rapidly and securely, into mission critical operations that modernize and enable critical national imperatives.
We are approximately 24,000 strong; driven by mission, united by purpose, and inspired by opportunities. SAIC is an Equal Opportunity Employer, fostering a culture of diversity, equity and inclusion, which is core to our values and important to attract and retain exceptional talent. Headquartered in
GAAP to Non-GAAP Guidance Reconciliation
The Company does not provide a reconciliation of forward-looking adjusted diluted EPS to GAAP diluted EPS or adjusted EBITDA margin to GAAP net income due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because certain deductions for non-GAAP exclusions used to calculate net income may vary significantly based on actual events, the Company is not able to forecast GAAP diluted EPS or GAAP net income with reasonable certainty. The variability of the above charges may have an unpredictable and potentially significant impact on our future GAAP financial results.
Forward-Looking Statements
Certain statements in this release contain or are based on “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “guidance,” and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about future dividends, share repurchases and other capital deployment plans. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website at www.saic.com or on the SEC’s website at www.sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC’s expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.
| Schedule 1: | ||||||||||||||||
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONDENSED AND CONSOLIDATED STATEMENTS OF INCOME (Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
February 2,
|
|
February 3,
|
|
February 2,
|
|
February 3,
|
||||||||
|
|
(in millions, except per share amounts) |
||||||||||||||
Revenues |
|
$ |
1,737 |
|
|
$ |
1,968 |
|
|
$ |
7,444 |
|
|
$ |
7,704 |
|
Cost of revenues |
|
|
1,545 |
|
|
|
1,746 |
|
|
|
6,572 |
|
|
|
6,816 |
|
Selling, general and administrative expenses |
|
|
114 |
|
|
|
102 |
|
|
|
373 |
|
|
|
374 |
|
Acquisition and integration costs |
|
|
— |
|
|
|
2 |
|
|
|
1 |
|
|
|
13 |
|
Gain on divestitures, net of transaction costs |
|
|
— |
|
|
|
— |
|
|
|
(240 |
) |
|
|
— |
|
Other operating income |
|
|
(1 |
) |
|
|
— |
|
|
|
(3 |
) |
|
|
— |
|
Operating income |
|
|
79 |
|
|
|
118 |
|
|
|
741 |
|
|
|
501 |
|
Interest expense, net |
|
|
32 |
|
|
|
32 |
|
|
|
120 |
|
|
|
118 |
|
Other (income) expense, net |
|
|
(1 |
) |
|
|
1 |
|
|
|
1 |
|
|
|
8 |
|
Income before income taxes |
|
|
48 |
|
|
|
85 |
|
|
|
620 |
|
|
|
375 |
|
Provision for income taxes |
|
|
(9 |
) |
|
|
(10 |
) |
|
|
(143 |
) |
|
|
(72 |
) |
Net income |
|
$ |
39 |
|
|
$ |
75 |
|
|
$ |
477 |
|
|
$ |
303 |
|
Net income attributable to non-controlling interest |
|
|
— |
|
|
|
1 |
|
|
|
— |
|
|
|
3 |
|
Net income attributable to common stockholders |
|
$ |
39 |
|
|
$ |
74 |
|
|
$ |
477 |
|
|
$ |
300 |
|
Weighted-average number of shares outstanding: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
|
52.0 |
|
|
|
54.6 |
|
|
|
53.1 |
|
|
|
55.3 |
|
Diluted |
|
|
52.7 |
|
|
|
55.3 |
|
|
|
53.7 |
|
|
|
55.8 |
|
Earnings per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
$ |
0.75 |
|
|
$ |
1.36 |
|
|
$ |
8.98 |
|
|
$ |
5.42 |
|
Diluted |
|
$ |
0.74 |
|
|
$ |
1.34 |
|
|
$ |
8.88 |
|
|
$ |
5.38 |
|
| Schedule 2: | ||||||||
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONDENSED AND CONSOLIDATED BALANCE SHEETS (Unaudited) |
||||||||
|
|
February 2,
|
|
February 3,
|
||||
|
|
(in millions) |
||||||
ASSETS |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
94 |
|
$ |
109 |
||
Receivables, net |
|
|
914 |
|
|
|
936 |
|
Inventory, prepaid expenses and other current assets |
|
|
123 |
|
|
|
152 |
|
Total current assets |
|
|
1,131 |
|
|
|
1,197 |
|
Goodwill |
|
|
2,851 |
|
|
|
2,911 |
|
Intangible assets, net |
|
|
894 |
|
|
|
1,009 |
|
Property, plant, and equipment, net |
|
|
91 |
|
|
|
92 |
|
Operating lease right of use assets |
|
|
152 |
|
|
|
158 |
|
Deferred income taxes |
|
|
— |
|
|
|
14 |
|
Other assets |
|
|
195 |
|
|
|
162 |
|
Total assets |
|
$ |
5,314 |
|
|
$ |
5,543 |
|
|
|
|
|
|
||||
LIABILITIES AND EQUITY |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable and accrued liabilities |
|
$ |
711 |
|
|
$ |
767 |
|
Accrued payroll and employee benefits |
|
|
370 |
|
|
|
328 |
|
Long-term debt, current portion |
|
|
77 |
|
|
|
31 |
|
Total current liabilities |
|
|
1,158 |
|
|
|
1,126 |
|
Long-term debt, net of current portion |
|
|
2,022 |
|
|
|
2,343 |
|
Operating lease liabilities |
|
|
147 |
|
|
|
152 |
|
Deferred income taxes |
|
|
28 |
|
|
|
— |
|
Other long-term liabilities |
|
|
174 |
|
|
|
218 |
|
Equity: |
|
|
|
|
||||
Total common stockholders' equity |
|
|
1,785 |
|
|
|
1,694 |
|
Non-controlling interest |
|
|
— |
|
|
|
10 |
|
Total stockholders' equity |
|
|
1,785 |
|
|
|
1,704 |
|
Total liabilities and stockholders' equity |
|
$ |
5,314 |
|
|
$ |
5,543 |
|
| Schedule 3: | |||||||||||||||
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONDENSED AND CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
February 2,
|
|
February 3,
|
|
February 2,
|
|
February 3,
|
||||||||
|
(in millions) |
||||||||||||||
Cash flows from operating activities: |
|
|
|
|
|
|
|
||||||||
Net income |
$ |
39 |
|
|
$ |
75 |
|
|
$ |
477 |
|
|
$ |
303 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
36 |
|
|
|
39 |
|
|
|
142 |
|
|
|
157 |
|
Amortization of off-market customer contracts |
|
— |
|
|
|
(2 |
) |
|
|
(5 |
) |
|
|
(14 |
) |
Amortization of debt issuance costs |
|
3 |
|
|
|
1 |
|
|
|
7 |
|
|
|
9 |
|
Deferred income taxes |
|
16 |
|
|
|
12 |
|
|
|
(17 |
) |
|
|
(17 |
) |
Stock-based compensation expense |
|
26 |
|
|
|
13 |
|
|
|
68 |
|
|
|
48 |
|
Gain on divestitures |
|
— |
|
|
|
— |
|
|
|
(247 |
) |
|
|
— |
|
Impairment of assets |
|
— |
|
|
|
4 |
|
|
|
— |
|
|
|
4 |
|
Other |
|
(5 |
) |
|
|
— |
|
|
|
(8 |
) |
|
|
— |
|
Increase (decrease) resulting from changes in operating assets and liabilities, net of the effect of the acquisitions and divestitures: |
|
|
|
|
|
|
|
||||||||
Receivables |
|
96 |
|
|
|
123 |
|
|
|
(46 |
) |
|
|
79 |
|
Inventory, prepaid expenses, and other current assets |
|
(56 |
) |
|
|
(17 |
) |
|
|
(43 |
) |
|
|
(10 |
) |
Other assets |
|
(19 |
) |
|
|
1 |
|
|
|
(14 |
) |
|
|
6 |
|
Accounts payable and accrued liabilities |
|
(128 |
) |
|
|
(47 |
) |
|
|
13 |
|
|
|
(9 |
) |
Accrued payroll and employee benefits |
|
53 |
|
|
|
(68 |
) |
|
|
49 |
|
|
|
(36 |
) |
Operating lease assets and liabilities, net |
|
(1 |
) |
|
|
(2 |
) |
|
|
(4 |
) |
|
|
(3 |
) |
Other long-term liabilities |
|
3 |
|
|
|
13 |
|
|
|
24 |
|
|
|
15 |
|
Net cash provided by operating activities |
|
63 |
|
|
|
145 |
|
|
|
396 |
|
|
|
532 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
||||||||
Expenditures for property, plant, and equipment |
|
(11 |
) |
|
|
(7 |
) |
|
|
(27 |
) |
|
|
(25 |
) |
Purchases of marketable securities |
|
(2 |
) |
|
|
(2 |
) |
|
|
(8 |
) |
|
|
(7 |
) |
Sales of marketable securities |
|
1 |
|
|
|
1 |
|
|
|
6 |
|
|
|
4 |
|
Proceeds from divestitures |
|
— |
|
|
|
— |
|
|
|
356 |
|
|
|
— |
|
Cash divested upon deconsolidation of joint venture |
|
— |
|
|
|
— |
|
|
|
(8 |
) |
|
|
— |
|
Other |
|
2 |
|
|
|
(5 |
) |
|
|
(5 |
) |
|
|
(8 |
) |
Net cash (used in) provided by investing activities |
|
(10 |
) |
|
|
(13 |
) |
|
|
314 |
|
|
|
(36 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
||||||||
Dividend payments to stockholders |
|
(19 |
) |
|
|
(20 |
) |
|
|
(79 |
) |
|
|
(83 |
) |
Principal payments on borrowings |
|
(166 |
) |
|
|
(210 |
) |
|
|
(441 |
) |
|
|
(990 |
) |
Issuances of stock |
|
4 |
|
|
|
4 |
|
|
|
17 |
|
|
|
16 |
|
Stock repurchased and retired or withheld for taxes on equity awards |
|
(89 |
) |
|
|
(59 |
) |
|
|
(382 |
) |
|
|
(267 |
) |
Proceeds from borrowings |
|
— |
|
|
|
210 |
|
|
|
160 |
|
|
|
840 |
|
Debt issuance costs |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(6 |
) |
Distributions to non-controlling interest |
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
|
(3 |
) |
Net cash used in financing activities |
|
(270 |
) |
|
|
(76 |
) |
|
|
(725 |
) |
|
|
(493 |
) |
Net (decrease) increase in cash, cash equivalents and restricted cash |
|
(217 |
) |
|
|
56 |
|
|
|
(15 |
) |
|
|
3 |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
320 |
|
|
|
62 |
|
|
|
118 |
|
|
|
115 |
|
Cash, cash equivalents and restricted cash at end of period |
$ |
103 |
|
|
$ |
118 |
|
|
$ |
103 |
|
|
$ |
118 |
|
| Schedule 4: | |||||||||
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION BACKLOG (Unaudited) |
|||||||||
The estimated value of our total backlog as of the dates presented was: |
|||||||||
|
|
February 2,
|
|
November 3,
|
|
February 3,
|
|||
|
|
(in millions) |
|||||||
Funded backlog |
|
$ |
3,539 |
|
$ |
4,036 |
|
$ |
3,554 |
Negotiated unfunded backlog |
|
|
19,224 |
|
|
19,102 |
|
|
20,248 |
Total backlog |
|
$ |
22,763 |
|
$ |
23,138 |
|
$ |
23,802 |
Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts and task orders as work is performed and excludes contract awards which have been protested by competitors until the protest is resolved in our favor. SAIC segregates backlog into two categories, funded backlog and negotiated unfunded backlog. Funded backlog for contracts with government agencies primarily represents contracts for which funding is appropriated less revenues previously recognized on these contracts, and does not include the unfunded portion of contracts where funding is incrementally appropriated or authorized by the
| Schedule 5: | ||||||||||||||||
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION NON-GAAP FINANCIAL MEASURES (Unaudited) |
||||||||||||||||
|
||||||||||||||||
| This schedule describes the non-GAAP financial measures included in this earnings release. While we believe that these non-GAAP financial measures may be useful in evaluating our financial information, they should be considered as supplemental in nature and not as a substitute for financial information prepared in accordance with GAAP. Reconciliations, definitions, and how we believe these measures are useful to management and investors are provided below. Other companies may define similar measures differently. | ||||||||||||||||
|
||||||||||||||||
EBITDA, Adjusted EBITDA and Adjusted Operating Income |
||||||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
February 2,
|
|
February 3,
|
|
February 2,
|
|
February 3,
|
||||||||
|
|
(in millions) |
||||||||||||||
Revenues |
|
$ |
1,737 |
|
|
$ |
1,968 |
|
|
$ |
7,444 |
|
|
$ |
7,704 |
|
Net income |
|
|
39 |
|
|
|
75 |
|
|
|
477 |
|
|
|
303 |
|
Interest expense, net and loss on sale of receivables |
|
|
34 |
|
|
|
36 |
|
|
|
129 |
|
|
|
126 |
|
Provision for income taxes |
|
|
9 |
|
|
|
10 |
|
|
|
143 |
|
|
|
72 |
|
Depreciation and amortization |
|
|
36 |
|
|
|
39 |
|
|
|
142 |
|
|
|
157 |
|
EBITDA(1) |
|
$ |
118 |
|
|
$ |
160 |
|
|
$ |
891 |
|
|
$ |
658 |
|
EBITDA as a percentage of revenues |
|
|
6.8 |
% |
|
|
8.1 |
% |
|
|
12.0 |
% |
|
|
8.5 |
% |
Acquisition and integration costs |
|
|
— |
|
|
|
2 |
|
|
|
1 |
|
|
|
13 |
|
Restructuring and impairment costs |
|
|
15 |
|
|
|
17 |
|
|
|
23 |
|
|
|
24 |
|
Depreciation included in acquisition and integration costs and restructuring and impairment costs |
|
|
(1 |
) |
|
|
(2 |
) |
|
|
(1 |
) |
|
|
(3 |
) |
Recovery of acquisition and integration costs and restructuring and impairment costs |
|
|
(5 |
) |
|
|
(6 |
) |
|
|
(6 |
) |
|
|
(12 |
) |
Gain on divestitures, net of transaction costs |
|
|
— |
|
|
|
— |
|
|
|
(240 |
) |
|
|
— |
|
Adjusted EBITDA(1) |
|
$ |
127 |
|
|
$ |
171 |
|
|
$ |
668 |
|
|
$ |
680 |
|
Adjusted EBITDA as a percentage of revenues |
|
|
7.3 |
% |
|
|
8.7 |
% |
|
|
9.0 |
% |
|
|
8.8 |
% |
|
|
|
|
|
|
|
|
|
||||||||
Operating income |
|
$ |
79 |
|
|
$ |
118 |
|
|
$ |
741 |
|
|
$ |
501 |
|
Operating income as a percentage of revenues |
|
|
4.5 |
% |
|
|
6.0 |
% |
|
|
10.0 |
% |
|
|
6.5 |
% |
Acquisition and integration costs |
|
|
— |
|
|
|
2 |
|
|
|
1 |
|
|
|
13 |
|
Restructuring and impairment costs |
|
|
15 |
|
|
|
17 |
|
|
|
23 |
|
|
|
24 |
|
Recovery of acquisition and integration costs and restructuring and impairment costs |
|
|
(5 |
) |
|
|
(6 |
) |
|
|
(6 |
) |
|
|
(12 |
) |
Gain on divestitures, net of transaction costs |
|
|
— |
|
|
|
— |
|
|
|
(240 |
) |
|
|
— |
|
Adjusted operating income(1) |
|
$ |
89 |
|
|
$ |
131 |
|
|
$ |
519 |
|
|
$ |
526 |
|
Adjusted operating income as a percentage of revenues |
|
|
5.1 |
% |
|
|
6.7 |
% |
|
|
7.0 |
% |
|
|
6.8 |
% |
EBITDA is a performance measure that is calculated by taking net income and excluding interest and loss on sale of receivables, provision for income taxes, and depreciation and amortization. Adjusted EBITDA and adjusted operating income are performance measures that exclude the impact of non-recurring transactions that we do not consider to be indicative of our ongoing operating performance. The acquisition and integration costs relate to the Company's acquisitions. The gain on divestitures includes gains associated with the deconsolidation of FSA and the sale of the logistics and supply chain management business, net of transaction costs. We believe that these performance measures provide management and investors with useful information in assessing trends in our ongoing operating performance and may provide greater visibility in understanding the long-term financial performance of the Company. |
||||||||||||||||
| |
||||||||||||||||
| (1)Non-GAAP measure, see above for definition. | ||||||||||||||||
| Schedule 5 (continued): | |||||||||||||||||||||||||||
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION NON-GAAP FINANCIAL MEASURES (Unaudited) |
|||||||||||||||||||||||||||
Adjusted Diluted Earnings Per Share |
|||||||||||||||||||||||||||
|
Three Months Ended February 2, 2024 |
||||||||||||||||||||||||||
|
As Reported |
|
Acquisition and
|
|
Restructuring
|
|
Recovery of
|
|
Amortization of
|
|
Gain on
|
|
Non-GAAP
|
||||||||||||||
Income before income taxes |
|
48 |
|
|
|
— |
|
|
15 |
|
|
|
(5 |
) |
|
|
29 |
|
|
|
— |
|
|
87 |
|
||
Income tax expense |
|
(9 |
) |
|
|
— |
|
|
|
(1 |
) |
|
|
1 |
|
|
|
(5 |
) |
|
|
2 |
|
|
|
(12 |
) |
Net income attributable to common stockholders |
$ |
39 |
|
|
$ |
— |
|
|
$ |
14 |
|
|
$ |
(4 |
) |
|
$ |
24 |
|
|
$ |
2 |
|
|
$ |
75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Diluted EPS attributable to common stockholders |
$ |
0.74 |
|
|
$ |
— |
|
|
$ |
0.27 |
|
|
$ |
(0.08 |
) |
|
$ |
0.46 |
|
|
$ |
0.04 |
|
|
$ |
1.43 |
|
|
Three Months Ended February 3, 2023 |
||||||||||||||||||||||
|
As Reported |
|
Acquisition and
|
|
Restructuring and
|
|
Recovery of
|
|
Amortization of
|
|
Non-GAAP
|
||||||||||||
Income before income taxes |
|
85 |
|
|
|
2 |
|
|
17 |
|
|
(6 |
) |
|
|
31 |
|
|
129 |
|
|||
Income tax expense |
|
(10 |
) |
|
|
— |
|
|
|
(2 | ) |
|
|
1 |
|
|
|
(4 | ) |
|
|
(15 |
) |
Net Income |
|
75 |
|
|
|
2 |
|
|
|
15 |
|
|
|
(5 |
) |
|
|
27 |
|
|
|
114 |
|
Less: Net income attributable to non-controlling interest |
|
1 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
Net income attributable to common stockholders |
$ |
74 |
|
|
$ |
2 |
|
|
$ |
15 |
|
|
$ |
(5 |
) |
|
$ |
27 |
|
|
$ |
113 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Diluted EPS attributable to common stockholders |
$ |
1.34 |
|
|
$ |
0.03 |
|
|
$ |
0.27 |
|
|
$ |
(0.09 |
) |
|
$ |
0.49 |
|
|
$ |
2.04 |
|
Adjusted diluted earnings per share is a performance measure that excludes the impact of non-recurring transactions that we do not consider to be indicative of our ongoing operating performance. The acquisition and integration costs relate to the Company's acquisitions. The gain on divestitures includes gain associated the sale of the logistics and supply chain management business, net of transaction costs. Adjusted diluted earnings per share also excludes amortization of intangible assets because we do not have a history of significant acquisition activity, we do not acquire businesses on a predictable cycle, and the amount of an acquisition's purchase price allocated to intangible assets and the related amortization term are unique to each acquisition. We believe that this performance measure provides management and investors with useful information in assessing trends in our ongoing operating performance and may provide greater visibility in understanding the long-term financial performance of the Company. |
|||||||||||||||||||||||
| |
|||||||||||||||||||||||
| (1)Non-GAAP measure, see above for definition. | |||||||||||||||||||||||
| Schedule 5 (continued): | |||||||||||||||||||||||||||
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION NON-GAAP FINANCIAL MEASURES (Unaudited) |
|||||||||||||||||||||||||||
Adjusted Diluted Earnings Per Share |
|||||||||||||||||||||||||||
|
Year Ended February 2, 2024 |
||||||||||||||||||||||||||
|
As Reported |
|
Acquisition and
|
|
Restructuring
|
|
Recovery of
|
|
Amortization of
|
|
Gain on
|
|
Non-GAAP
|
||||||||||||||
Income before income taxes |
|
620 |
|
|
|
1 |
|
|
23 |
|
|
|
(6 |
) |
|
|
115 |
|
|
|
(240 |
) |
|
|
513 |
|
|
Income tax expense |
|
(143 |
) |
|
|
— |
|
|
|
(2 |
) |
|
|
1 |
|
|
|
(21 |
) |
|
|
75 |
|
|
|
(90 |
) |
Net income attributable to common stockholders |
$ |
477 |
|
|
$ |
1 |
|
|
$ |
21 |
|
|
$ |
(5 |
) |
|
$ |
94 |
|
|
$ |
(165 |
) |
|
$ |
423 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Diluted EPS attributable to common stockholders |
$ |
8.88 |
|
|
$ |
0.02 |
|
|
$ |
0.39 |
|
|
$ |
(0.09 |
) |
|
$ |
1.75 |
|
|
$ |
(3.07 |
) |
|
$ |
7.88 |
|
|
Year Ended February 3, 2023 |
||||||||||||||||||||||
|
As Reported |
|
Acquisition and
|
|
Restructuring and
|
|
Recovery of
|
|
Amortization of
|
|
Non-GAAP
|
||||||||||||
Income before income taxes |
|
375 |
|
|
|
13 |
|
|
|
24 |
|
|
|
(12 |
) |
|
|
125 |
|
|
|
525 |
|
Income tax expense |
|
(72 |
) |
|
|
(2 |
) |
|
|
(5 |
) |
|
|
2 |
|
|
|
(24 |
) |
|
|
(101 |
) |
Net Income |
$ |
303 |
|
|
$ |
11 |
|
|
$ |
19 |
|
|
$ |
(10 |
) |
|
$ |
101 |
|
|
$ |
424 |
|
Less: Net income attributable to non-controlling interest |
|
3 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3 |
|
Net income attributable to common stockholders |
$ |
300 |
|
|
$ |
11 |
|
|
$ |
19 |
|
|
$ |
(10 |
) |
|
$ |
101 |
|
|
$ |
421 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Diluted EPS attributable to common stockholders |
$ |
5.38 |
|
|
$ |
0.20 |
|
|
$ |
0.34 |
|
|
$ |
(0.18 |
) |
|
$ |
1.81 |
|
|
$ |
7.55 |
|
Adjusted diluted earnings per share is a performance measure that excludes the impact of non-recurring transactions that we do not consider to be indicative of our ongoing operating performance. The acquisition and integration costs relate to the Company's acquisitions. The gain on divestitures includes gains associated with the deconsolidation of FSA and the sale of the logistics and supply chain management business, net of transaction costs. Adjusted diluted earnings per share also excludes amortization of intangible assets because we do not have a history of significant acquisition activity, we do not acquire businesses on a predictable cycle, and the amount of an acquisition's purchase price allocated to intangible assets and the related amortization term are unique to each acquisition. We believe that this performance measure provides management and investors with useful information in assessing trends in our ongoing operating performance and may provide greater visibility in understanding the long-term financial performance of the Company. |
|||||||||||||||||||||||
| |
|||||||||||||||||||||||
| (1)Non-GAAP measure, see above for definition. | |||||||||||||||||||||||
| Schedule 5 (continued): | |||||||||||||||
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION NON-GAAP FINANCIAL MEASURES (Unaudited) |
|||||||||||||||
Free Cash Flow |
|||||||||||||||
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
February 2,
|
|
February 3,
|
|
February 2,
|
|
February 3,
|
||||||||
|
(in millions) |
||||||||||||||
Net cash provided by operating activities |
$ |
63 |
|
|
$ |
145 |
|
|
$ |
396 |
|
|
$ |
532 |
|
Expenditures for property, plant, and equipment |
|
(11 |
) |
|
|
(7 |
) |
|
|
(27 |
) |
|
|
(25 |
) |
Cash used (provided) by MARPA Facility |
|
45 |
|
|
|
10 |
|
|
|
45 |
|
|
|
(50 |
) |
Free cash flow(1) |
$ |
97 |
|
|
$ |
148 |
|
|
$ |
414 |
|
|
$ |
457 |
|
L&SCM divestiture transaction fees |
|
— |
|
|
|
— |
|
|
|
7 |
|
|
|
— |
|
L&SCM divestiture cash taxes |
|
18 |
|
|
|
— |
|
|
|
74 |
|
|
|
— |
|
L&SCM divestiture transition services |
|
4 |
|
|
|
— |
|
|
|
(9 |
) |
|
|
— |
|
Transaction-adjusted free cash flow(1) |
$ |
119 |
|
|
$ |
148 |
|
|
$ |
486 |
|
|
$ |
457 |
|
|
|
FY25 Guidance |
|
|
(in millions) |
Net cash provided by operating activities |
|
|
Expenditures for property, plant, and equipment |
|
Approximately |
Free cash flow(1) |
|
|
Free cash flow is calculated by taking cash flows provided by operating activities less expenditures for property, plant, and equipment and less cash flows from our Master Accounts Receivable Purchasing Agreement ("MARPA Facility") for the sale of certain designated eligible |
||
| |
||
| (1)Non-GAAP measure, see above for definition. | ||
View source version on businesswire.com: https://www.businesswire.com/news/home/20240315356837/en/
Investor Relations: Joe DeNardi, +1.703.488.8528, joseph.w.denardi@saic.com
Media: Thais Hanson, +1.703.676.8215, publicrelations@saic.com
Source: Science Applications International Corp.
FAQ
What were SAIC's Q4 FY24 revenues?
What was SAIC's FY24 net income?
What were SAIC's Q4 FY24 diluted earnings per share?
What were SAIC's Q4 FY24 cash flows provided by operating activities?
What did SAIC update in its FY25 guidance?
